Breaking

Jerusalem Daily: Who gets to run in Israel’s elections? Olivia Dean accused of plagiarism on her I’ve Seen It track Palestine Action activists used whips and hammers to threaten guards at arms factory, court hears ‘My GCSEs were exhausting’: Patrick McCabe’s success reveals the limits of Send tech Top Democrats slam ‘Trump’s failing economic agenda’ after weaker-than-expected jobs growth – US politics live Watch: Why has UK diesel price hit an all time high? Jerusalem Daily: Who gets to run in Israel’s elections? Olivia Dean accused of plagiarism on her I’ve Seen It track Palestine Action activists used whips and hammers to threaten guards at arms factory, court hears ‘My GCSEs were exhausting’: Patrick McCabe’s success reveals the limits of Send tech Top Democrats slam ‘Trump’s failing economic agenda’ after weaker-than-expected jobs growth – US politics live Watch: Why has UK diesel price hit an all time high?

Business

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

adminOctober 2, 20261 min read

Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.

The post Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s appeared first on Business News.

admin

Leave a Comment Cancel reply

News Interlink. All rights reserved © 2026 . Developed By: MM